NL192563C - Vloeibaar farmaceutisch preparaat voor toediening via de neus dat een in de natuur voorkomend calcitonine bevat. - Google Patents

Vloeibaar farmaceutisch preparaat voor toediening via de neus dat een in de natuur voorkomend calcitonine bevat. Download PDF

Info

Publication number
NL192563C
NL192563C NL8303386A NL8303386A NL192563C NL 192563 C NL192563 C NL 192563C NL 8303386 A NL8303386 A NL 8303386A NL 8303386 A NL8303386 A NL 8303386A NL 192563 C NL192563 C NL 192563C
Authority
NL
Netherlands
Prior art keywords
administration
calcitonin
nasal
preparation
salmon calcitonin
Prior art date
Application number
NL8303386A
Other languages
English (en)
Dutch (nl)
Other versions
NL8303386A (nl
NL192563B (nl
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27449393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL192563(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB838320865A external-priority patent/GB8320865D0/en
Priority claimed from GB838322528A external-priority patent/GB8322528D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NL8303386A publication Critical patent/NL8303386A/nl
Publication of NL192563B publication Critical patent/NL192563B/xx
Application granted granted Critical
Publication of NL192563C publication Critical patent/NL192563C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8303386A 1982-10-05 1983-10-03 Vloeibaar farmaceutisch preparaat voor toediening via de neus dat een in de natuur voorkomend calcitonine bevat. NL192563C (nl)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8228390 1982-10-05
GB8228390 1982-10-05
GB8236928 1982-12-30
GB8236928 1982-12-30
GB838320865A GB8320865D0 (en) 1983-08-03 1983-08-03 Organic compounds
GB8320865 1983-08-03
GB838322528A GB8322528D0 (en) 1983-08-22 1983-08-22 Organic compounds
GB8322528 1983-08-22

Publications (3)

Publication Number Publication Date
NL8303386A NL8303386A (nl) 1984-05-01
NL192563B NL192563B (nl) 1997-06-02
NL192563C true NL192563C (nl) 1997-10-03

Family

ID=27449393

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8303386A NL192563C (nl) 1982-10-05 1983-10-03 Vloeibaar farmaceutisch preparaat voor toediening via de neus dat een in de natuur voorkomend calcitonine bevat.

Country Status (21)

Country Link
US (2) US5759565A (da)
JP (1) JPH07103043B2 (da)
AT (1) AT394947B (da)
AU (2) AU572800B2 (da)
CA (1) CA1220138A (da)
CH (1) CH657779A5 (da)
DE (1) DE3335086A1 (da)
DK (1) DK161800C (da)
FR (1) FR2533826B1 (da)
HK (1) HK27389A (da)
HU (1) HU192246B (da)
IL (1) IL69892A (da)
IT (1) IT1172324B (da)
KE (1) KE3848A (da)
MY (1) MY8700271A (da)
NL (1) NL192563C (da)
NZ (1) NZ205846A (da)
PH (1) PH22725A (da)
PT (1) PT77443B (da)
SE (1) SE455671B (da)
SG (1) SG76388G (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AU783952B2 (en) 2000-02-04 2006-01-05 Unigene Laboratories, Inc. Nasal calcitonin formulations
US6531112B2 (en) * 2000-05-15 2003-03-11 Delrx Pharmaceutical Corporation Formulations for administering calcitonin and processes for preparing the same
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
MXPA05006572A (es) * 2002-12-17 2005-12-14 Nastech Pharm Co Composiciones y metodos para la administracion mejorada por via mucosa de peptidos fijadores al receptor de y2 y metodos para tratar y prevenir la obesidad.
US7229966B2 (en) * 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
US7186692B2 (en) * 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
US7166575B2 (en) * 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
WO2005037256A2 (de) * 2003-10-15 2005-04-28 Pari Gmbh Flüssige zubereitung enthaltend tobramycin
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20100256060A1 (en) * 2009-04-02 2010-10-07 Unigene Laboratories Inc. Peptide pharmaceuticals for nasal delivery
KR101855242B1 (ko) 2012-01-26 2018-05-09 크리스토퍼 제이. 소레스 펩타이드 호르몬의 칼시토닌 cgrp 패밀리의 펩타이드 길항제 및 그의 용도
WO2018045083A1 (en) 2016-09-02 2018-03-08 Soares Christopher J Use of cgrp receptor antagonists in neuroprotection and neurological disorders
US10723716B2 (en) 2016-12-21 2020-07-28 New York University Alpha-helix mimetics as modulators of Abeta self-assembly
US11124479B2 (en) 2017-07-14 2021-09-21 New York University Oligopyrroles as antagonists of islet amyloid polypeptide oligomerization
US10500197B2 (en) 2017-07-18 2019-12-10 New York University Use of oligopyridylamides to inhibit mutant p53 amyloid formation and restore its tumor suppressor function

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769405A (en) * 1970-04-17 1973-10-30 Armour Pharma Methods for obtaining diuresis
CH539556A (de) * 1971-03-16 1973-07-31 Ciba Geigy Ag Applikator zur dosierten Ausgabe einer Flüssigkeit
GB1354526A (en) * 1971-04-19 1974-06-05 Armour Pharma Preparation for obtaining diuresis in animals
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
GB2008403B (en) * 1977-11-04 1982-07-28 Christie R B Parsons J A Pharmaceutical compositions
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
DE2903957A1 (de) * 1979-02-02 1980-08-07 Boehringer Sohn Ingelheim Mittel zur behandlung der nasalen hypersekretion
JPS5625197A (en) * 1979-07-19 1981-03-10 Microbial Chem Res Found Cleomycin and its preparation
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS56122309A (en) * 1980-03-03 1981-09-25 Teijin Ltd Calcitonin pharmaceutical for rectal administration
EP0053754B1 (de) * 1980-12-06 1986-04-23 Reichert, Dietrich, Dr. med. Mittel zur Bekämpfung des Schnarchens und Verfahren zu dessen Anwendung
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina

Also Published As

Publication number Publication date
NZ205846A (en) 1987-09-30
DK161800B (da) 1991-08-19
SG76388G (en) 1989-03-23
AT394947B (de) 1992-07-27
IL69892A0 (en) 1984-01-31
NL8303386A (nl) 1984-05-01
IT1172324B (it) 1987-06-18
AU2103588A (en) 1988-12-22
HU192246B (en) 1987-05-28
ATA349483A (de) 1992-01-15
HK27389A (en) 1989-04-07
SE455671B (sv) 1988-08-01
PT77443B (en) 1986-04-11
DK161800C (da) 1992-01-27
CH657779A5 (de) 1986-09-30
DE3335086C2 (da) 1990-09-20
CA1220138A (en) 1987-04-07
DK458183D0 (da) 1983-10-04
AU1984983A (en) 1984-04-12
IL69892A (en) 1987-12-31
DE3335086A1 (de) 1984-05-03
MY8700271A (en) 1987-12-31
JPH07103043B2 (ja) 1995-11-08
PH22725A (en) 1988-11-28
US5759565A (en) 1998-06-02
SE8305485D0 (sv) 1983-10-05
US5733569A (en) 1998-03-31
IT8349105A0 (it) 1983-10-05
SE8305485L (sv) 1984-04-06
JPH02262526A (ja) 1990-10-25
KE3848A (en) 1989-03-31
DK458183A (da) 1984-04-06
FR2533826B1 (fr) 1987-06-12
AU572800B2 (en) 1988-05-19
HUT34121A (en) 1985-02-28
FR2533826A1 (fr) 1984-04-06
NL192563B (nl) 1997-06-02
PT77443A (en) 1983-11-01

Similar Documents

Publication Publication Date Title
NL192563C (nl) Vloeibaar farmaceutisch preparaat voor toediening via de neus dat een in de natuur voorkomend calcitonine bevat.
GB2127689A (en) Calcitonin inhalation compositions
EP0999841B1 (en) Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
US20050079139A1 (en) Minoxidil pharmaceutical foam formulation
USRE43580E1 (en) Nasal calcitonin formulations
HU199678B (en) Process for producing aerosols containing nitroglicerol
EP0973501B1 (en) Aqueous suspension for nasal administration of loteprednol
FI102873B (fi) Menetelmä nitroglyseriinipitoisen, hydrofiilisen vesipitoisen pumpatta van sumutteen valmistamiseksi
US5281580A (en) Calcitonin-containing emulsion for nasal administration
US20110218206A1 (en) Individual and combination of mdivi-1 and nutlin-3 for topical or intravitreal ophthalmic use
JP4753448B2 (ja) パルミチン酸レチノール、レチノールの安定化方法及びビタミン類水溶液
JPH0672869A (ja) ナトリウムクロモグリケートの水性医薬組成物
JPH0354647B2 (da)
JP3533228B2 (ja) 低刺激性ニトログリセリン組成物及びスプレー剤
EP1314428A1 (en) Oct preparations
IE56602B1 (en) Galenic compositions comprising calcitonin and their use
IE56601B1 (en) Galenic compositions comprising calcitonin and their use
JP2001039922A (ja) ソルビン酸類の分解抑制方法及び液剤組成物
DK174540B1 (da) Fremgangsmåde til fremstilling af et flydende farmaceutisk præparat indeholdende calcitonin og beholder indeholdende et sådant præparat
DE112019000683T5 (de) Intranasale epinephrin-formulierungen und verfahren zur behandlung von erkrankungen
BR102017010943A2 (pt) composição farmacêutica oftálmica de bimatoprosta para tratamento de glaucoma e seu respectivo uso
JPH0525057A (ja) カルシトニンを含有する医薬組成物
IT9048064A1 (it) Composizioni farmaceutiche a base di calcitonina somministrabili per via nasale in terapia umana

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20031003